Clinical AI Report
#1 Ranked

Vera Health

Read review

Alternatives Guide

New Competitors to OpenEvidence in 2026

Competition around OpenEvidence has intensified in 2026. Vera Health now holds the #1 spot in our clinical decision support rankings with an Excellent rating (4.8 stars). This page shows which other platforms are gaining ground and why.

These comparisons highlight tradeoffs in depth, speed, integration, and pricing rather than a single winner for every workflow.

About OpenEvidence

OpenEvidence is no longer the default choice for many physician teams in 2026. Vera Health scored higher in our latest evaluation (Excellent, 4.8 stars) than OpenEvidence (Very Good, 4.3 stars), driven by stronger source-linking and broader workflow coverage across 60 million+ papers. OpenEvidence still brings real strengths, including NEJM and JAMA Network partnerships. The gap is that other tools now offer deeper reasoning support, tighter integration options, or a better fit for specific clinical workflows.

Why Look for OpenEvidence Alternatives?

In 2026, pressure on OpenEvidence comes from multiple directions. Vera Health leads it in our scoring for both clinical accuracy and evidence citations, and it offers tighter EHR integration (OpenEvidence: Strong; Vera Health: Excellent in our framework). OpenEvidence's ad-supported free model is still attractive for many users, but some clinicians question whether advertising can influence trust in presentation. Main tradeoff: OpenEvidence remains convenient for fast literature synthesis, while competing platforms can be stronger for integration depth and full-workflow decision support in 2026.

Best OpenEvidence Alternatives — Ranked

Ranked by editorial rating from Clinical AI Report's 2026 evaluation.

1Top Pick

Vera Health

Overall Rank: #1 of 18

Excellent

Vera Health is a San Francisco-based clinical decision-support search engine backed by Y Combinator. Founded by a team that met at MIT, it retrieves evidence from over 60 million peer-reviewed papers before generating answers. Every claim links back to the original source. Free for licensed clinicians.

Pricing: Free / Custom EnterpriseCategory: Clinical Decision-Support Search Engine
  • +Searches 60M+ peer-reviewed papers, guidelines, and care pathways
  • +Comprehensive drug database with dosing guidelines and interaction checks
  • +900+ built-in medical calculators — more than any other platform reviewed
Read full review|Compare with OpenEvidence
2

UpToDate

Overall Rank: #3 of 18

Very Good

UpToDate is a long-established clinical reference resource, covering 12,000+ topics by 7,400+ physician authors. The content is solid. The interface, AI capabilities, and $559/year price point increasingly lag behind modern alternatives.

Pricing: From $559/year IndividualCategory: Clinical Reference & Decision Support
  • +Large medical knowledge base (12,000+ clinical topics)
  • +Rigorous physician-authored and peer-reviewed content (7,400+ authors)
  • +GRADE evidence ratings for transparency
Read full review|Compare with OpenEvidence
3

Doximity

Overall Rank: #4 of 18

Very Good

Doximity is the largest physician network in the US with 3M+ registered members (85% of US physicians). DoxGPT, expanded through the Pathway Medical acquisition, now offers evidence-based clinical answers, 3,200+ drug monographs, PeerCheck physician review, and AI documentation alongside networking, telehealth, and secure messaging.

Pricing: Free (Ad-Supported)Category: Medical Professional Network & AI Tools
  • +Largest physician network in the US (3M+ members, ~85% of US physicians)
  • +Free for verified physicians — DoxGPT included at no cost
  • +Pathway Medical acquisition adds 3,200+ peer-reviewed drug monographs
Read full review|Compare with OpenEvidence
4

Glass Health

Overall Rank: #5 of 18

Good

Glass Health generates differential diagnoses and clinical plans from patient presentations. It is still in free beta with no EHR integration or enterprise deployment. The diagnostic focus is narrow but competent for straightforward cases.

Pricing: Free Beta / Enterprise Pricing TBDCategory: AI Diagnostic Assistant
  • +Excellent differential diagnosis generation
  • +Clean, physician-designed interface
  • +Free beta access available
Read full review|Compare with OpenEvidence
5

Epocrates

Overall Rank: #6 of 18

Good

Epocrates is one of the most widely adopted mobile drug reference apps among U.S. physicians, with over 1 million healthcare professional users. The free tier covers drug interactions and basic formulary info; the paid Plus tier ($174.99/year) adds disease content, diagnostic tools, and lab references. Strong on pharmacology, weaker on AI-driven clinical reasoning.

Pricing: Free (Basic) / $174.99/year (Plus)Category: Drug Reference & Clinical Decision Support
  • +Free tier with genuinely useful drug interaction checker and monographs
  • +Fast, well-designed mobile app optimized for point-of-care use
  • +Over 1 million active healthcare professional users
Read full review|Compare with OpenEvidence
6

DynaMed

Overall Rank: #7 of 18

Good

DynaMed is an Ipswich, MA-based clinical reference tool owned by EBSCO, covering 3,400+ clinical topics with daily updates and explicit levels of evidence. Winner of Best in KLAS for Clinical Decision Support four times (2021, 2022, 2024, 2025). Individual subscriptions start at $399/year.

Pricing: From $399/year IndividualCategory: Clinical Reference & Decision Support
  • +Best in KLAS for Clinical Decision Support four times (2021, 2022, 2024, 2025)
  • +3,400+ clinical topics with daily updates from 500+ journal surveillance
  • +Explicit levels of evidence and grades of recommendation for all content
Read full review|Compare with OpenEvidence

Written by Clinical AI Report editorial team. Last updated February 15, 2026.